Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989;12(3):134-44.

Metabolism of bilirubin and riboflavin in the course of phototherapy for hyperbilirubinaemia in the newborns

Affiliations
  • PMID: 2509172

Metabolism of bilirubin and riboflavin in the course of phototherapy for hyperbilirubinaemia in the newborns

E Knobloch et al. Czech Med. 1989.

Abstract

The study of bilirubin photochemical degradation in the presence of riboflavin has shown that, in this case, the primary process is photooxidation during which riboflavin acts as a receptor and bilirubin as a donor of electrons. The reaction proceeds under anaerobic conditions in an equilibrated manner, under aerobic ones as a catalytic process during which the catalyst, i. e., riboflavin is regenerated. The primary intermediate product is biliverdin in vitro, later this is further broken down. For the purpose of studying the mechanism of this process liquid chromatography and computerized technique based on solving nonlinear differential equations have been used. It appears that during phototherapy in the newborn infant there develops a decrease of the blood level of riboflavin reaching up to hypovitaminotic values and a transient biliverdin level elevation. Oral riboflavin administration may maintain this level within physiological range and at the same time shorten the necessary duration of phototherapy. In severe cases of hyperbilirubinaemia a shift of the ratio between flavin-adenin-dinucleotide and free riboflavin, as compared to the physiological state, has been recorded. The results of this work are discussed in the light of our current knowledge concerning the mechanisms of bilirubin breakdown during prototherapy.

PubMed Disclaimer

Similar articles

Cited by

  • Fetal and neonatal bilirubin metabolism.
    Itoh S, Okada H, Koyano K, Nakamura S, Konishi Y, Iwase T, Kusaka T. Itoh S, et al. Front Pediatr. 2023 Feb 7;10:1002408. doi: 10.3389/fped.2022.1002408. eCollection 2022. Front Pediatr. 2023. PMID: 36824297 Free PMC article. Review.